334 related articles for article (PubMed ID: 25112877)
21. Mitochondrial fission causes cisplatin resistance under hypoxic conditions via ROS in ovarian cancer cells.
Han Y; Kim B; Cho U; Park IS; Kim SI; Dhanasekaran DN; Tsang BK; Song YS
Oncogene; 2019 Nov; 38(45):7089-7105. PubMed ID: 31409904
[TBL] [Abstract][Full Text] [Related]
22. Prohibitin levels regulate OMA1 activity and turnover in neurons.
Anderson CJ; Kahl A; Fruitman H; Qian L; Zhou P; Manfredi G; Iadecola C
Cell Death Differ; 2020 Jun; 27(6):1896-1906. PubMed ID: 31819158
[TBL] [Abstract][Full Text] [Related]
23. Oxidative insults disrupt OPA1-mediated mitochondrial dynamics in cultured mammalian cells.
Garcia I; Innis-Whitehouse W; Lopez A; Keniry M; Gilkerson R
Redox Rep; 2018 Dec; 23(1):160-167. PubMed ID: 29961397
[TBL] [Abstract][Full Text] [Related]
24. A threshold of transmembrane potential is required for mitochondrial dynamic balance mediated by DRP1 and OMA1.
Jones E; Gaytan N; Garcia I; Herrera A; Ramos M; Agarwala D; Rana M; Innis-Whitehouse W; Schuenzel E; Gilkerson R
Cell Mol Life Sci; 2017 Apr; 74(7):1347-1363. PubMed ID: 27858084
[TBL] [Abstract][Full Text] [Related]
25. Regulation of OPA1 processing and mitochondrial fusion by m-AAA protease isoenzymes and OMA1.
Ehses S; Raschke I; Mancuso G; Bernacchia A; Geimer S; Tondera D; Martinou JC; Westermann B; Rugarli EI; Langer T
J Cell Biol; 2009 Dec; 187(7):1023-36. PubMed ID: 20038678
[TBL] [Abstract][Full Text] [Related]
26. Loss of OMA1 delays neurodegeneration by preventing stress-induced OPA1 processing in mitochondria.
Korwitz A; Merkwirth C; Richter-Dennerlein R; Tröder SE; Sprenger HG; Quirós PM; López-Otín C; Rugarli EI; Langer T
J Cell Biol; 2016 Jan; 212(2):157-66. PubMed ID: 26783299
[TBL] [Abstract][Full Text] [Related]
27. OMA1 mediates OPA1 proteolysis and mitochondrial fragmentation in experimental models of ischemic kidney injury.
Xiao X; Hu Y; Quirós PM; Wei Q; López-Otín C; Dong Z
Am J Physiol Renal Physiol; 2014 Jun; 306(11):F1318-26. PubMed ID: 24671334
[TBL] [Abstract][Full Text] [Related]
28. p53 is a determinant of X-linked inhibitor of apoptosis protein/Akt-mediated chemoresistance in human ovarian cancer cells.
Fraser M; Leung BM; Yan X; Dan HC; Cheng JQ; Tsang BK
Cancer Res; 2003 Nov; 63(21):7081-8. PubMed ID: 14612499
[TBL] [Abstract][Full Text] [Related]
29. MicroRNA-148a-3p enhances cisplatin cytotoxicity in gastric cancer through mitochondrial fission induction and cyto-protective autophagy suppression.
Li B; Wang W; Li Z; Chen Z; Zhi X; Xu J; Li Q; Wang L; Huang X; Wang L; Wei S; Sun G; Zhang X; He Z; Zhang L; Zhang D; Xu H; El-Rifai W; Xu Z
Cancer Lett; 2017 Dec; 410():212-227. PubMed ID: 28965855
[TBL] [Abstract][Full Text] [Related]
30. p32/C1QBP regulates OMA1-dependent proteolytic processing of OPA1 to maintain mitochondrial connectivity related to mitochondrial dysfunction and apoptosis.
Noh S; Phorl S; Naskar R; Oeum K; Seo Y; Kim E; Kweon HS; Lee JY
Sci Rep; 2020 Jun; 10(1):10618. PubMed ID: 32606429
[TBL] [Abstract][Full Text] [Related]
31. OPA1 processing in cell death and disease - the long and short of it.
MacVicar T; Langer T
J Cell Sci; 2016 Jun; 129(12):2297-306. PubMed ID: 27189080
[TBL] [Abstract][Full Text] [Related]
32. A Common Missense Variant in OMA1 Associated with the Prognosis of Heart Failure.
Hu D; Li S; Hu S; Sun Y; Xiao L; Li C; Wang J; Wang Y; Ni L; Zhao C; Wang DW
Cardiovasc Drugs Ther; 2020 Jun; 34(3):345-356. PubMed ID: 32236861
[TBL] [Abstract][Full Text] [Related]
33. The Mitochondrial PHB2/OMA1/DELE1 Pathway Cooperates with Endoplasmic Reticulum Stress to Facilitate the Response to Chemotherapeutics in Ovarian Cancer.
Cheng M; Yu H; Kong Q; Wang B; Shen L; Dong D; Sun L
Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163244
[TBL] [Abstract][Full Text] [Related]
34. Leptin increases mitochondrial OPA1 via GSK3-mediated OMA1 ubiquitination to enhance therapeutic effects of mesenchymal stem cell transplantation.
Yang F; Wu R; Jiang Z; Chen J; Nan J; Su S; Zhang N; Wang C; Zhao J; Ni C; Wang Y; Hu W; Zeng Z; Zhu K; Liu X; Hu X; Zhu W; Yu H; Huang J; Wang J
Cell Death Dis; 2018 May; 9(5):556. PubMed ID: 29748581
[TBL] [Abstract][Full Text] [Related]
35. Cisplatin induced apoptosis of ovarian cancer A2780s cells by activation of ERK/p53/PUMA signals.
Song H; Wei M; Liu W; Shen S; Li J; Wang L
Histol Histopathol; 2018 Jan; 33(1):73-79. PubMed ID: 28287251
[TBL] [Abstract][Full Text] [Related]
36. Loss of Yme1L perturbates mitochondrial dynamics.
Ruan Y; Li H; Zhang K; Jian F; Tang J; Song Z
Cell Death Dis; 2013 Oct; 4(10):e896. PubMed ID: 24176854
[TBL] [Abstract][Full Text] [Related]
37. Saikosaponin-d, a calcium mobilizing agent, sensitizes chemoresistant ovarian cancer cells to cisplatin-induced apoptosis by facilitating mitochondrial fission and G2/M arrest.
Tsuyoshi H; Wong VKW; Han Y; Orisaka M; Yoshida Y; Tsang BK
Oncotarget; 2017 Nov; 8(59):99825-99840. PubMed ID: 29245943
[TBL] [Abstract][Full Text] [Related]
38. Cell fate regulation by gelsolin in human gynecologic cancers.
Abedini MR; Wang PW; Huang YF; Cao M; Chou CY; Shieh DB; Tsang BK
Proc Natl Acad Sci U S A; 2014 Oct; 111(40):14442-7. PubMed ID: 25246592
[TBL] [Abstract][Full Text] [Related]
39. Mdm2 antagonists induce apoptosis and synergize with cisplatin overcoming chemoresistance in TP53 wild-type ovarian cancer cells.
Mir R; Tortosa A; Martinez-Soler F; Vidal A; Condom E; Pérez-Perarnau A; Ruiz-Larroya T; Gil J; Giménez-Bonafé P
Int J Cancer; 2013 Apr; 132(7):1525-36. PubMed ID: 22961628
[TBL] [Abstract][Full Text] [Related]
40. Down-regulation of X-linked inhibitor of apoptosis protein induces apoptosis in chemoresistant human ovarian cancer cells.
Sasaki H; Sheng Y; Kotsuji F; Tsang BK
Cancer Res; 2000 Oct; 60(20):5659-66. PubMed ID: 11059757
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
